Aspect Analytics

Executive Summary

Aspect Analytics, based in Leuven, Belgium, is a pioneer in transforming spatial and multimodal biological data into actionable insights for drug discovery and development. Its proprietary platform, Weave®, integrates spatial transcriptomics, proteomics, mass spectrometry imaging (MSI), and histology at enterprise scale. By leveraging AI and machine learning, the platform enables researchers to uncover complex biological relationships within tissue microenvironments, accelerating target identification, biomarker discovery, and preclinical validation. Aimed at pharmaceutical and biotech companies, Aspect Analytics addresses the growing need for high-resolution spatial analysis in precision medicine, positioning itself as a key enabler of next-generation therapeutics. The company operates at the preclinical stage, focusing on R&D collaborations and platform enhancements to drive adoption.

Upcoming Catalysts (preview)

• Q4 2026Major pharmaceutical partnership for Weave® platform60% success
• Q2 2027Series B funding round to expand commercial operations55% success
• Q3 2026Launch of Weave® cloud-based enterprise solution70% success